GLP-1s and Birth Control: Does Zepbound or Ozempic Affect the Pill?

The short version

If you take the pill, this is not a footnote. Tirzepatide — sold as Zepbound for weight loss and Mounjaro for diabetes — carries an explicit FDA warning that oral hormonal contraceptives may become less effective, and the label advises switching to a non-oral method or adding a barrier method for four weeks after you start and for four weeks after each dose increase¹. Injectable semaglutide (Wegovy, Ozempic) does not carry that warning, and a dedicated study found it did not reduce the absorption of a combined oral contraceptive³. So the honest headline is molecule-specific: on tirzepatide, assume the pill needs backup around starting and every dose bump; on injectable semaglutide, the pill is not expected to be undermined. For a mother who is not planning a pregnancy right now, getting this right is exactly as important as the weight loss itself.

This is educational only, not medical advice — but it's a genuine drug difference that a lot of weight-loss coverage skips.

Why tirzepatide can blunt the pill

The mechanism is the same one behind the nausea and fullness: these drugs slow how fast the stomach empties, and that slowing is most pronounced right after the first dose and after each dose increase. A pill you swallow has to be absorbed from the gut on a fairly predictable schedule; when gastric emptying is delayed and variable, the amount of hormone that actually gets absorbed can drop. A pharmacokinetic review of GLP-1 and dual GIP/GLP-1 medications describes exactly this — delayed gastric emptying altering the absorption of co-administered oral drugs, including oral contraceptives, following tirzepatide². It's strongest early and after escalation, which is precisely the window the FDA label tells you to cover with a backup method¹.

Why injectable semaglutide is different

You'd expect semaglutide to do the same thing — it also slows gastric emptying — but the contraception data don't bear that out. In a dedicated study, women took a combined ethinylestradiol/levonorgestrel pill before and during semaglutide treatment, and semaglutide did not reduce the bioavailability of either hormone³. That's why the Wegovy label doesn't carry tirzepatide's oral-contraceptive warning⁴. The practical read: on injectable semaglutide, your oral birth control is not expected to be weakened. (A caution worth naming: if severe vomiting or diarrhea is causing you to lose a pill dose, that can reduce effectiveness with any medication — a general sick-day rule, not a semaglutide-specific interaction.)

One more nuance mothers ask about: this warning is about the drug's effect on absorption. If you're on tirzepatide and having significant GI side effects, that's a double reason to have a backup method — both the slowed absorption and any vomiting can matter. Our guide to managing GLP-1 side effects covers the GI piece.

What this means in practice

• On tirzepatide (Zepbound/Mounjaro) and relying on the pill? Talk to your clinician about a non-oral method — an IUD, implant, injection, patch, or ring — or add a barrier method (like condoms) for four weeks after starting and four weeks after every dose increase¹. Non-oral methods sidestep the gut-absorption problem entirely.
• On injectable semaglutide (Wegovy/Ozempic)? Your oral contraceptive is not expected to be affected^3,4, though the general sick-day rule about lost doses from vomiting or diarrhea still applies.
• Not sure which situation is yours? Bring the exact product name to the conversation. The molecule, not the marketing category, decides this.

The bigger reason contraception belongs in this conversation

There's a second, non-negotiable reason to get birth control right on a GLP-1: these drugs are not used in pregnancy. The semaglutide label advises discontinuing at least two months before a planned pregnancy, because of the drug's long half-life⁴ — roughly a week per dose is the half-life itself, not the stopping instruction, and quoting it as the instruction understates the window several times over. The same logic does not transfer to tirzepatide: its label carries no pre-pregnancy interval and instead says to discontinue once a pregnancy is recognized. An unplanned pregnancy on a GLP-1 is precisely what effective contraception exists to prevent — so "is my birth control still working" isn't only about avoiding pregnancy in general, it's about avoiding a pregnancy while on a medication you'd need to stop. If conceiving is the goal, that's a planned washout, not a surprise — and if you have PCOS, note that weight loss can restore ovulation and fertility that felt unreliable before, which our PCOS evidence guide discusses.

How to choose a provider that handles this well

This is a small question with a big consequence, and it's a fast test of whether a program is actually practicing medicine. A provider that asks what contraception you use before prescribing tirzepatide — and adjusts the plan around dose increases — is doing the job; one that never raises it is a red flag. For how the two molecules compare more broadly, see Zepbound vs Wegovy for a mother and our guide to GLP-1s, your cycle, and reproductive hormones.